1. Combined endocrine and targeted therapy in luminal breast cancer
   Marcelle Goldner et al, 2021, Expert Review of Anticancer Therapy CrossRef
2. p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer
   Freda Halim et al, 2022, F1000Research CrossRef
3. Notch Signaling Pathway and Endocrine Resistance in Breast Cancer
   Jing-Wen Bai et al, 2020, Frontiers in Pharmacology CrossRef
4. Epigenetic Therapies and Biomarkers in Breast Cancer
   Lauren Julia Brown et al, 2022, Cancers CrossRef
5. p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer
   Freda Halim et al, 2022, F1000Research CrossRef
6. SREBF2-AS1 Promotes the Growth of Breast Cancer via Regulating Cholesterol Anabolism
   玲 邵, 2022, World Journal of Cancer Research CrossRef